NFKB1 and amyotrophic lateral sclerosis: In agreement with our results, a recent study on a mouse model of ALS, expressing the humanTDP-43A315T mutation which affects motor function, showed that Wse treatment can reduce Nuclear Factor Kappa Beta (NF-κB) activation and neuroinflammation, and ameliorate motor defects34.